🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications ◆
Updated 12 Aug 2026 · ClinicalTrials.gov

Clinical Trials in Cork

← All Irish trials

Every active and recruiting clinical study with an Irish site — searchable by condition, sponsor, phase and location. Refreshed daily from the ClinicalTrials.gov registry.

16
Recruiting now
31
Active studies
Recruiting
Generating Intervals of Reference FFor Early Life Brain Biomarkers.
Reference Intervals, Biomarker in Early Diagnosis, Neonatal
University College Cork · started 2026-04-13
📍 Cork
NCT07585149 on ClinicalTrials.gov ↗
Recruiting Phase 3
DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemotherapy
Small Cell Lung Cancer (SCLC), Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Boehringer Ingelheim · started 2026-04-13
📍 Cork
NCT07472517 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant
Multiple Myeloma
European Myeloma Network B.V. · started 2025-12-23
📍 Cork · Dublin · Limerick
NCT06932562 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Breast Neoplasms, Neoplasm Metastasis
Eli Lilly and Company · started 2025-12-22
📍 Cork · Dublin · Galway
NCT07174336 on ClinicalTrials.gov ↗
Recruiting
The Satiety Control Optimization by Nutritional Enhancement Study
Metabolic Diseases, Type 2 Diabetes, Cardiovascular Disease
University College Cork · started 2025-08-18
📍 Cork
NCT07420023 on ClinicalTrials.gov ↗
Recruiting Phase 3
Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH1-Mutated AML or MDS/AML Considered Ineligible for Intensive Chemotherapy
Acute Myeloid Leukemia
Stichting Hemato-Oncologie voor Volwassenen Nederland · started 2025-08-05
📍 Cork · Dublin · Galway
NCT07075016 on ClinicalTrials.gov ↗
Active Phase 3
Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers)
Allergy, Peanut Allergy
DBV Technologies · started 2025-06-24
📍 Cork · Dublin
NCT07003919 on ClinicalTrials.gov ↗
Recruiting
AI-driven Narrow-band Imaging Score for Disease Assessment and Outcome Prediction in Ulcerative Colitis
Ulcerative Colitis (UC)
University College Cork · started 2024-11-04
📍 Cork
NCT06709209 on ClinicalTrials.gov ↗
Recruiting
Microbiome Immunotherapy Neoadjuvant Assessment
Triple Negative Breast Cancer
University College Cork · started 2024-10-02
📍 Cork
NCT06709651 on ClinicalTrials.gov ↗
Starting soon
Environmental Influence on Mental Illness Via Modifications of Genomes and Metabolomes in Adolescents With Autism
Autism, Autism Spectrum Disorder
University College Cork · started 2024-09
📍 Cork
NCT06299618 on ClinicalTrials.gov ↗
Recruiting
Investigating Mechanistic Predictors of Interpatient Variability and Temozolomide (TMZ) Induced Haematological Toxicity for Glioma Patients
Glioma
University College Cork · started 2024-08-22
📍 Cork
NCT06546631 on ClinicalTrials.gov ↗
Recruiting Phase 3
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Merck Sharp & Dohme LLC · started 2024-06-24
📍 Cork · Dublin · Galway
NCT06393374 on ClinicalTrials.gov ↗
Recruiting Phase 1
A Phase 1/1b Study of IAM1363 in HER2 Cancers
HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer, HER2 + Breast Cancer
Iambic Therapeutics, Inc · started 2024-03-25
📍 Dublin · Cork
NCT06253871 on ClinicalTrials.gov ↗
Active Phase 3
Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005)
Endometrial Cancer
Merck Sharp & Dohme LLC · started 2023-12-06
📍 Cork · Dublin
NCT06132958 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
Spine SABR - Dose-escalated Stereotactic Ablative Body Radiotherapy (SABR) for Solid Tumour Spine Metastases
Solid Tumor Spine Metastases
Cancer Trials Ireland · started 2023-11-21
📍 Cork · Dublin
NCT06078813 on ClinicalTrials.gov ↗
Starting soon Phase 3
Surveillance After Resection of Oesophageal aNd Gastric Cancer (SARONG-II) Trial
Esophageal Cancer, Gastric Cancer
University of Dublin, Trinity College · started 2023-11
📍 Cork · Dublin · Galway
NCT06115629 on ClinicalTrials.gov ↗
Active Phase 3
An Early Access Study of Ivosidenib in Patients With a Pretreated Locally Advanced or Metastatic Cholangiocarcinoma
Cholangiocarcinoma
Servier Affaires Médicales · started 2023-05-03
📍 Cork · Dublin
NCT05876754 on ClinicalTrials.gov ↗
Active Phase 3
A Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)
Systemic Lupus Erythematosus
Bristol-Myers Squibb · started 2023-01-12
📍 Manorhamilton · Cork · Dublin
NCT05617677 on ClinicalTrials.gov ↗
Recruiting
30% or 60% Oxygen at Birth to Improve Neurodevelopmental Outcomes in Very Low Birthweight Infants
Premature Infant, Respiratory Distress Syndrome in Premature Infant, Neurodevelopmental Outcome
University of Alberta · started 2022-06-27
📍 Cork
NCT03825835 on ClinicalTrials.gov ↗
Active Phase 3
A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)
Carcinoma, Renal Cell
Merck Sharp & Dohme LLC · started 2022-03-15
📍 Dublin · Cork
NCT05239728 on ClinicalTrials.gov ↗
Active Phase 3
Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma (MK-3475-C93/KEYNOTE-C93/GOG-3064/ENGOT-en15)
Endometrial Neoplasms
Merck Sharp & Dohme LLC · started 2022-02-03
📍 Cork · Dublin
NCT05173987 on ClinicalTrials.gov ↗
Active Phase 3
Ibrutinib Monotherapy Versus Fixed-duration Venetoclax Plus Obinutuzumab Versus Fixed-duration Ibrutinib Plus Venetoclax in Patients With Previously Untreated Chronic Lymphocytic Leukaemia (CLL)
Chronic Lymphoid Leukemia
German CLL Study Group · started 2021-03-01
📍 Cork · Dublin · Galway · Limerick · Waterford
NCT04608318 on ClinicalTrials.gov ↗
Active Phase 3
An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK2 Inhibitor Therapy and Who Require Red Blood Cell Transfusions
Myeloproliferative Disorders, Myelofibrosis, Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis
Celgene · started 2021-02-25
📍 Cork · Dublin
NCT04717414 on ClinicalTrials.gov ↗
Recruiting
iCorMicA - Stratified Medicine in Angina
Microvascular Angina, Angina, Stable, Ischemia With No Obstructive Coronary Arteries (INOCA), Coronary Microvascular Dysfunction (CMD)
NHS Greater Glasgow and Clyde · started 2020-12-30
📍 Cork · Dublin
NCT04674449 on ClinicalTrials.gov ↗
Recruiting Phase 3
ErythroPOietin Alfa to Prevent Mortality and Reduce Severe Disability in Critically Ill TRAUMA Patients
Trauma, Traumatic Injury, Traumatic Brain Injury, Wounds and Injuries
Australian and New Zealand Intensive Care Research Centre · started 2020-11-09
📍 Beaumont · Cork · Dublin
NCT04588311 on ClinicalTrials.gov ↗
Active Phase 2
Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study
Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor Positive Breast Carcinoma, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8
ECOG-ACRIN Cancer Research Group · started 2020-09-15
📍 Cork
NCT04316117 on ClinicalTrials.gov ↗
Active Phase 3
Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Low Grade Fallopian Tube Serous Adenocarcinoma, Ovarian Low Grade Serous Adenocarcinoma, Primary Peritoneal Low Grade Serous Adenocarcinoma, Stage II Fallopian Tube Cancer AJCC v8
NRG Oncology · started 2019-09-20
📍 Cork · Dublin
NCT04095364 on ClinicalTrials.gov ↗
Active Phase 3
Phase III Radium 223 mCRPC-PEACE III
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC · started 2015-10
📍 Cork · Dublin
NCT02194842 on ClinicalTrials.gov ↗
Active Phase 3
PALbociclib CoLlaborative Adjuvant Study
Breast Cancer
Alliance Foundation Trials, LLC. · started 2015-08
📍 Cork · Dublin · Limerick · Sligo · Waterford
NCT02513394 on ClinicalTrials.gov ↗
Recruiting
Breast Cancer Proteomics and Molecular Heterogeneity
Primary Breast Cancer, Recurrent/Metastatic Breast Cancer
Cancer Trials Ireland · started 2013-02
📍 Cork · Dublin · Limerick · Waterford
NCT01840293 on ClinicalTrials.gov ↗
Active Phase 3
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Breast Ductal Carcinoma In Situ, Invasive Breast Carcinoma, Multicentric Breast Carcinoma, Multifocal Breast Carcinoma
National Cancer Institute (NCI) · started 2011-02-28
📍 Cork · Dublin · Mount Merrion · Galway · Limerick · Sligo
NCT01272037 on ClinicalTrials.gov ↗
No trials match your search.

Browse by location

Dublin · 81 Cork · 31 Galway · 18 Limerick · 11 Waterford · 7 Beaumont · 3 Sligo · 2 Ballinasloe · 2 Mount Merrion · 1 Tallaght · 1 Abbotstown · 1 Drogheda · 1

Browse by condition

Breast Cancer · 5 Carcinoma, Renal Cell · 3 Down Syndrome · 2 Homocystinuria · 2 HIV · 2 HIV Infections · 2 Endometrial Cancer · 2 Amyotrophic Lateral Sclerosis · 2 Multiple Myeloma · 2 Triple Negative Breast Cancer · 2 Cancer · 2 Persistent Atrial Fibrillation · 2 Fallopian Tube Cancer · 2 Hypertension · 2 Cardiovascular Diseases · 2 Small Cell Lung Cancer (SCLC) · 2
Cite this page

Priya Life Science (2026). Clinical Trials in Ireland Tracker. Available at: https://priyalifescience.com/clinical-trials-ireland/city/cork (Accessed: 12 August 2026).

Embed this data ↗

Source: ClinicalTrials.gov, U.S. National Library of Medicine — studies listing at least one Irish site, refreshed daily. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. For trials across the wider EU, see our EU Clinical Trials Tracker.